A novel antifungal analog peptide derived from protaetiamycine
2009
Lee, J.Y., Kyungpook National University, Daegu, Republic of Korea | Hong, H.J., Kyungpook National University, Daegu, Republic of Korea | Kim, J.K., Konkuk University, Seoul, Republic of Korea | Hwang, J.S., National Academy of Agricultural Science, RDA, Suwon, Republic of Korea | Kim, Y.M., Konkuk University, Seoul, Republic of Korea | Lee, D.G., Kyungpook National University, Daegu, Republic of Korea
Previously, the 9-mer analog peptides, 9Pbw2 and 9Pbw4, were designed based on a defensin-like peptide, protaetiamycine isolated from Protaetia brevitarsis. In this study, antifungal effects of the analog peptides were investigated. The antifungal susceptibility testing exhibited that 9Pbw4 contained more potent antifungal activities than 9Pbw2. A PI influx assay confirmed the effects of the analog peptides and demonstrated that the peptides exerted their activity by a membrane-active mechanism, in an energy-independent manner. As the noteworthy potency of 9Pbw4, the mechanism(s) of 9Pbw4 were further investigated. The membrane studies, using rhodamine-labeled giant unilamellar vesicle (GUV) and fluorescein isothiocyanate (FITC)-dextran loaded liposome, suggested that the membrane-active mechanism of 9Pbw4 could have originated from the poreforming action and the radii of pores was presumed to be anywhere from 1.8 nm to 3.3 nm. These results were confirmed by 3D-flow cytometric contour-plot analysis. The present study suggests a potential of 9Pbw4 as a novel antifungal peptide.
Show more [+] Less [-]AGROVOC Keywords
Bibliographic information
This bibliographic record has been provided by Korea Agricultural Science Digital Library
